Do CIRM’s regulations seek to ensure Californians pay a fair price for drugs they helped create?
Yes. Grantees, Collaborators and Exclusive Licensees, and their successors and assigns, must participate in the CalRx program and provide a Drug, the development of which was in whole or in part the result of CIRM-Funded Research, to those eligible at the CalRx prices. Grantees/Collaborators/Exclusive Licensees must also provide Drugs to publicly-funded purchasers at one of the benchmarks described in CalRx. The benchmarks are: • Eighty-five percent of the average manufacturer price for a drug, as published by the Centers for Medicare and Medicaid Services. • The lowest price provided to any nonpublic entity in the state by a manufacturer to the extent that the Medicaid best price exists under federal law. • The Medicaid best price, to the extent that this price exists under Federal law.
